DOCSLIB.ORG

Biomol ICCB Known Bi#123261

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Biomol ICCB Known Bi#123261 (R)-Methanandamide 1,25-Dihydroxyvitamin D3 1,2-Didecanoyl-glycerol (10:0) 1,2-Dioctanoyl-sn-glycerol 1,2-Dioleoyl-glycerol (18:1) 10-Hydroxycamptothecin 11,12-Epoxyeicosatrienoic acid 12(R)-HETE 12(S)-HETE 12(S)-HPETE 12-Methoxydodecanoic acid 13(S)-HODE 13(S)-HPODE 13,14-Dihydro-prostaglandin E1 13-cis Retinoic acid 13-Ketooctadecadienoic acid 14,15-Epoxyeicosatrienoic acid 1400W 15(S)-HETE 15(S)-HPETE 15d-Prostaglandin J2 15-Ketoeicosatetraenoic acid 16,16-Dimethyl-prostaglandin E2 17-Allylamino-geldanamycin 17-Octadecynoic acid 17-Phenyl-trinor-prostaglandin E2 1-Acyl-PAF 1-Hexadecyl-2-arachidonoyl-glycerol 1-Hexadecyl-2-methylglycero-3 PC 1-Hexadecyl-2-O-acetyl-glycerol 1-Hexadecyl-2-O-methyl-glycerol 1-Octadecyl-2-methylglycero-3 PC 1-Oleoyl-2-acetyl-glycerol 1-Stearoyl-2-arachidonoyl-glycerol 1-Stearoyl-2-linoleoyl-glycerol 2,5-Ditertbutylhydroquinone 24(S)-Hydroxycholesterol 24,25-Dihydroxyvitamin D3 25-Hydroxyvitamin D3 2-Arachidonoylglycerol 2-Fluoropalmitic acid 2-Hydroxymyristic acid 2-Methoxyantimycin A3 3,4-Dichloroisocoumarin 4-Aminopyridine 4-Hydroxyphenylretinamide 4-Oxatetradecanoic acid 5(S)-HETE 5(S)-HPETE 5,6-Epoxyeicosatrienoic acid 5,8,11,14-Eicosatetraynoic acid 5,8,11-Eicosatriynoic acid 5-Hydroxydecanoate 5-Iodotubercidin 5-Ketoeicosatetraenoic acid 5'-N-Ethylcarboxamidoadenosine (NECA) 6,7-ADTN HBr 6-Formylindolo [3,2-B] carbazole 6-Keto-prostaglandin F1α 7,7-Dimethyleicosadienoic acid 8,9-Epoxyeicosatrienoic acid 8-EPI-prostaglandin F2α 8-Methoxymethyl-IBMX 9(S)-HODE 9(S)-HPODE 9,10-Octadecenoamide 9alpha,11beta-Prostaglandin F2 9beta,11alpha-Prostaglandin F2 9-cis Retinoic acid A-23187 A-3 AA-861 Acetyl (N)-S-farnesyl-L-cysteine Ac-Leu-Leu-Nle-CHO Aconitine Actinomycin D Adrenic acid (22:4, n-6) AG-1296 AG1478 AG213 (Tyrphostin 47) AG-370 AG-490 AG-879 AGC AGGC Ala-Ala-Phe-CMK Alamethicin Alrestatin AM 92016 AM-251 AM-580 Amantidine Amiloride Amino-1,8-naphthalimide [4-Amino-1,8-naphthalimide] Aminobenzamide (3-ABA) [3-Aminobenzamide (3-ABA)] Amiodarone Anandamide (18:2,n-6) Anandamide (20:3,n-6) Anandamide (20:4, n-6) Anandamide (22:4,n-6) Anisomycin Aphidicolin Arachidonamide Arachidonic acid (20:4, n-6) Arachidonoyl-PAF Aristolochic acid Arvanil Ascomycin (FK-520) B581 BADGE Bafilomycin A1 BAPTA-AM Bay 11-7082 Bay K-8644 Benzamil Bepridil Bestatin Betulinic acid Bezafibrate β-Lapachone Blebbistatin BML-190 Boc-GVV-CHO Bongkrekic acid Brefeldin A Bromo-7-nitroindazole [3-Bromo-7-nitroindazole] Bromo-cAMP [8-Bromo-cAMP] Bromo-cGMP [8-Bromo-cGMP] Bumetanide BW-B 70C C16 Ceramide C2 Ceramide C2 Dihydroceramide C8 Ceramide C8 Ceramine C8 Dihydroceramide CA-074-Me Calpeptin Calphostin C Calyculin A Camptothecin Cantharidin CAPE Capsacin(E) Capsazepine Carbacyclin Castanospermine CDC Cerulenin CGP-37157 Chelerythrine Ciglitazone Cimaterol CinnGEL 2Me Cirazoline CITCO Clofibrate Clonidine Cloprostenol Na Clozapine C-PAF Curcumin Cyclo [Arg-Gly-Asp-D-Phe-Val] Cycloheximide Cycloheximide-N-ethylethanoate Cyclopamine Cyclopiazonic acid Cyclosporin A Cypermethrin Cytochalasin B Cytochalasin D D609 Damnacanthal Dantrolene Decoyinine Decylubiquinone Delta 12-Prostaglandin J2 Deoxymannojirimycin(1) Deoxynorjrimycin(1) Deprenyl Dexamethasone Diazoxide Dibutyrylcyclic AMP Dibutyrylcyclic GMP Dichlorobenzamil Dihomo-gamma-linolenic acid Dihydrosphingosine Diindolylmethane Diltiazem Dimethyloxaloylglycine Diphenyleneiodonium Cl Dipyridamole DL-Dihydrosphingosine DL-PDMP DL-PPMP Docosahexaenoic acid (22:6 n-3) Docosapentaenoic acid Docosatrienoic acid (22:3 n-3) Doxorubicin DRB E-4031 E6 Berbamine E-64-d Ebselen EHNA HCl Eicosa-5,8-dienoic acid (20:2 n-12) Eicosadienoic acid (20:2 n-6) Eicosapentaenoic acid (20:5 n-3) Eicosatrienoic acid (20:3 n-3) Enantio-PAF C16 Epibatidine (±) Estradiol Etoposide Farnesylthioacetic acid FCCP Fipronil FK-506 Flecainide Flufenamic acid Flunarizine Fluprostenol Fluspiriline Forskolin FPL-64176 Fumonisin B1 Furoxan Geldanamycin Genistein GF-109203X Gingerol γ-Linolenic acid (18:3 n-6) Gliotoxin Glipizide Glyburide GM6001 Go6976 Grayanotoxin III GW-5074 GW-9662 H7 H-89 H9 HA-1004 HA1077 HA14-1 HBDDE Helenalin Hinokitiol Histamine HNMPA-(AM)3 Hoechst 33342 (cell permeable) (BisBenzimide) Huperzine A [(-)-Huperzine A] IAA-94 IB-MECA IBMX ICRF-193 Ikarugamyin Indirubin Indirubin-3'-monoxime Indomethacin Ionomycin Juglone K252A Kavain (±) KN-62 KT-5720 L-744,832 Latrunculin B Lavendustin A L-cis-Diltiazem Leukotoxin A (9,10-EODE) Leukotoxin B (12,13-EODE) Leukotriene B4 Leukotriene C4 Leukotriene D4 Leukotriene E4 Leupeptin LFM-A13 Lidocaine Linoleamide Linoleic acid Linolenic acid (18:3 n-3) L-NAME L-NASPA Loperamide LY-171883 LY-294002 LY-83583 Lycorine Lyso-PAF C16 Lysophosphatidic acid Manoalide Manumycin A MAPP, D-erythro MAPP, L-erythro Mastoparan MBCQ MCI-186 MDL-28170 Mead acid (20:3 n-9) Mead ethanolamide Methoprene acid Methotrexate Methoxy verapamil Mevinolin (Lovastatin) MG-132 Milrinone Minoxidil Minoxidil sulfate Misoprostol, free acid Mitomycin C ML7 ML9 MnTBAP Monastrol Monensin MY-5445 Mycophenolic acid N,N-Dimethylsphingosine N9-Isopropylolomoucine N-Acetyl-leukotriene E4 Nafamostst mesylate NapSul-Ile-Trp-CHO N-Arachidonoylglycine Nicardipine Nifedipine Niflumic acid Nigericin Niguldipine Nimesulide Nimodipine Nitrendipine N-Linoleoylglycine Nocodazole N-Phenylanthranilic acid NPPB NS-1619 NS-398 NSC-95397 OBAA Okadaic acid Oligomycin A Olomoucine Ouabain PAF C16 PAF C18 PAF C18:1 Palmitylethanolamide Parthenolide Paxilline PCA 4248 PCO-400 PD 98059 Penitrem A Pepstatin Phenamil Phenanthridinone [6(5H)-Phenanthridinone] Phenoxybenzamine Phentolamine Phenytoin Phorbol 12 myristate 13 acetate Phosphatidic acid, dipalmitoyl Piceatannol Pifithrin Pimozide Pinacidil Piroxicam PP1 PP2 Prazocin Pregnenolone 16α carbonitrile PRIMA-1 Procainamide Propafenone Propidium iodide Propranolol (S-) Prostaglandin A1 Prostaglandin A2 Prostaglandin B1 Prostaglandin B2 Prostaglandin D2 Prostaglandin E1 Prostaglandin E2 Prostaglandin F1α Prostaglandin F2α Prostaglandin I2 Na Prostaglandin J2 Puromycin Quercetin Quinidine Quinine QX-314 Rapamycin Resveratrol Retinoic acid, all trans REV-5901 RG-14620 RHC-80267 RK-682 Ro 20-1724 Ro 31-8220 Rolipram Roscovitine Rottlerin RWJ-60475-(AM)3 Ryanodine SB 202190 SB 203580 SB-415286 SB-431542 SDZ-201106 Serotonin S-Farnesyl-L-cysteine methyl ester Shikonin Siguazodan SKF-96365 SP-600125 Sphingosine Splitomycin SQ22536 SQ-29548 Staurosporine SU-4312 Swainsonine Tamoxifen Tanshinone IIA Taxol = Paclitaxel Tetrahydrocannabinol-7-oic acid Tetrandrine Thalidomide Thapsigargin Thiocitrulline [L-Thiocitrulline HCl] Thiorphan TMB-8 Tolazamide Tolbutamide Tosyl-Phe-CMK (TPCK) TPEN Trequinsin Trichostatin-A Trifluoperazine TRIM Triptolide TTNPB Tunicamycin Tyrphostin 1 Tyrphostin 9 Tyrphostin AG-126 Tyrphostin AG-825 Tyrphostin-8 U-0126 U-37883A U-46619 U-50488 U73122 U-74389G U-75302 Valinomycin Verapamil Veratridine Vinblastine Vinpocetine W7 WIN 55,212-2 Wiskostatin Wortmannin WY-14643 Xestospongin C Y-27632 YC-1 Yohimbine YS035 Zaprinast Zardaverine Z-Leu3-VS ZM226600 ZM336372 Z-Prolyl-prolinal Z-VAD-FMK.
Load more

Recommended publications
  • Molecular Mechanisms Underlying Ketamine-Mediated Inhibition Of
    Anesthesiology 2005; 102:93–101 © 2004 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Molecular Mechanisms Underlying Ketamine-mediated Inhibition of Sarcolemmal Adenosine Triphosphate- sensitive Potassium Channels Takashi Kawano, M.D.,* Shuzo Oshita, M.D.,† Akira Takahashi, M.D.,‡ Yasuo Tsutsumi, M.D.,* Katsuya Tanaka, M.D.,§ Yoshinobu Tomiyama, M.D.,࿣ Hiroshi Kitahata, M.D.,# Yutaka Nakaya, M.D.** Background: Ketamine inhibits adenosine triphosphate-sen- sensitive channel pore.3 These channels, as metabolic sitive potassium (KATP) channels, which results in the blocking sensors, are associated with such cellular functions as of ischemic preconditioning in the heart and inhibition of va- insulin secretion, cardiac preconditioning, vasodilata- sorelaxation induced by KATP channel openers. In the current 4–7 Downloaded from http://pubs.asahq.org/anesthesiology/article-pdf/102/1/93/357819/0000542-200501000-00017.pdf by guest on 27 September 2021 study, the authors investigated the molecular mechanisms of tion, and neuroprotection. ketamine’s actions on sarcolemmal KATP channels that are re- In cardiac myocytes, intravenous general anesthetics, associated by expressed subunits, inwardly rectifying potas- such as ketamine racemate, propofol, and thiamylal, di- sium channels (Kir6.1 or Kir6.2) and sulfonylurea receptors 8–10 rectly inhibit native sarcolemmal KATP channels. Al- (SUR1, SUR2A, or SUR2B). though these observations suggest that intravenous an- Methods: The authors used inside-out patch clamp configura- tions to investigate the effects of ketamine on the activities of esthetics may impair the endogenous organ protective reassociated Kir6.0/SUR channels containing wild-type, mutant, mechanisms mediated by KATP channels, the possibility or chimeric SURs expressed in COS-7 cells.
    [Show full text]
  • Betulinic Acid and Its Derivatives As Anti-Cancer Agent: a Review
    Available online a t www.scholarsresearchlibrary.com Scholars Research Library Archives of Applied Science Research, 2014, 6 (3):47-58 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-508X CODEN (USA) AASRC9 Betulinic acid and its derivatives as anti-cancer agent: A review Gomathi Periasamy*, Girma Teketelew, Mebrahtom Gebrelibanos, Biruk Sintayehu, Michael Gebrehiwot, Aman Karim and Gereziher Geremedhin Department of Pharmacy, College of Health Sciences, Mekelle University, Mekelle, Ethiopia _____________________________________________________________________________________________ ABSTRACT Betulinic acid is a known natural product which has gained a lot of attention in the recent years since it exhibits a variety of biological and medicinal properties. This review provides the most important anticancer properties of betulinic acid and its derivatives. _____________________________________________________________________________________________ INTRODUCTION Cancer is a group of diseases that cause cells in the body to change and grow out of control[1]. Cancer cell growth is different from normal cell growth. Instead of dying, cancer cells keep on growing and form new cancer cells. These cancer cells can grow into (invade) other tissues, something that normal cells cannot do. In most cases the cancer cells form a tumor. But some cancers, like leukemia, rarely form tumors. Instead, these cancer cells are in the blood and bone marrow[2]. Cancer cell escape from many of the normal homeostatic mechanism that control proliferation. They invade surrounding tissues, gets into the body’s circulating system and set up areas of proliferation away from the site of their original appearance[3]. Cancer is the second most important disease leading to death in both the developing and developed countries nowadays. The global burden of cancer continues to increase largely because of the aging and growth of the world population alongside an increasing adoption of cancer-causing behaviors, particularly smoking, in economically developing countries[4].
    [Show full text]
  • Biomol Average and SD Table S1.Xlsx
    Compound GliNS1 G179NS G166NS average, n=5 STD average, n=3 STD average, n=3 STD INTRACELLULAR CALCIUM Antibiotic A-23187 0.00 0.00 0.10 0.07 0.15 0.14 INTRACELLULAR CALCIUM Ryanodine 1.04 0.14 1.03 0.03 1.03 0.03 INTRACELLULAR CALCIUM Cyclopiazonic acid 1.01 0.06 0.88 0.05 0.92 0.06 INTRACELLULAR CALCIUM Gingerol 1.00 0.06 0.91 0.01 1.01 0.06 INTRACELLULAR CALCIUM Thapsigargin 0.00 0.01 0.00 0.00 0.10 0.12 INTRACELLULAR CALCIUM TMB-8 0.89 0.07 0.91 0.05 0.94 0.03 INTRACELLULAR CALCIUM Dantrolene 0.91 0.08 0.98 0.05 0.94 0.01 CALCIUM CHANNELS Amiloride 1.01 0.07 1.01 0.04 1.03 0.05 CALCIUM CHANNELS Benzamil 0.83 0.08 0.83 0.12 0.96 0.04 CALCIUM CHANNELS BAY K-8644 0.93 0.13 0.93 0.09 1.07 0.14 CALCIUM CHANNELS Diltiazem 0.96 0.07 0.99 0.12 0.94 0.14 CALCIUM CHANNELS L-cis-Diltiazem 0.91 0.17 1.01 0.12 0.95 0.12 CALCIUM CHANNELS Flunarizine 0.85 0.08 1.00 0.06 0.85 0.05 CALCIUM CHANNELS FPL-64176 0.99 0.11 0.95 0.07 1.05 0.05 CALCIUM CHANNELS Nifedipine 1.06 0.17 0.95 0.12 1.03 0.09 CALCIUM CHANNELS Nimodipine 1.05 0.06 0.95 0.03 1.06 0.17 CALCIUM CHANNELS Nitrendipine 0.99 0.07 0.96 0.10 1.04 0.09 CALCIUM CHANNELS SDZ-202791 R(-) 1.01 0.08 0.92 0.06 1.01 0.08 CALCIUM CHANNELS SKF-96365 0.73 0.05 0.70 0.11 0.69 0.04 CALCIUM CHANNELS Tetrandrine 0.47 0.07 0.76 0.16 0.87 0.20 CALCIUM CHANNELS Verapamil 1.01 0.02 0.89 0.07 1.06 0.20 CALCIUM CHANNELS Methoxy Verapamil 0.93 0.14 0.96 0.07 0.93 0.13 CALCIUM CHANNELS Bepridil 0.70 0.16 0.92 0.15 0.84 0.14 CALCIUM CHANNELS Amiodarone 0.32 0.12 0.58 0.07 0.48 0.23 CALCIUM CHANNELS YS035 1.00 0.16
    [Show full text]
  • Stimulatory Action of Telmisartan, an Antagonist of Angiotensin II Receptor, on Voltage-Gated Na+ Current: Experimental and Theoretical Studies
    Chinese Journal of Physiology 61(1): 1-13, 2018 1 DOI: 10.4077/CJP.2018.BAG516 Stimulatory Action of Telmisartan, an Antagonist of Angiotensin II Receptor, on Voltage-Gated Na+ Current: Experimental and Theoretical Studies Tzu-Tung Chang, Chia-Jung Yang, Yu-Chi Lee, and Sheng-Nan Wu Department of Physiology, National Cheng Kung University Medical College, Tainan 70101, Taiwan, Republic of China Abstract Telmisartan (Tel) is recognized as a non-peptide blocker of AT1R. Whether this agent has any direct effects on ion currents remains unexplored. In whole-cell current recordings, addition of Tel + increased the peak amplitude of voltage-gated Na (NaV) current (INa) accompanied by the increased time constant of INa inactivation in differentiated NSC-34 motor neuron-like cells. Tel-stimulated INa in these cells is unlinked to either blockade of AT1R or activation of peroxisome proliferator-activated receptor gamma (PPAR-γ). In order to explore how this compound affects the amplitude and kinetics of INa in neurons, a Hodgkin-Huxley-based (HH-based) model designed to mimic effect of Tel on the functional activities of neurons was computationally created in this study. In this framework, the parameter for h inactivation gating variable, which was changed in a stepwise fashion, was implemented + + to predict changes in membrane potentials (V) as a function of maximal Na (GNa), K conductance (GK), or both. As inactivation time course of INa was increased, the bifurcation point of V versus GNa became lower, and the range between subcritical and supercritical values at the bifurcation of V versus GK correspondingly became larger.
    [Show full text]
  • REVIEW Peroxisome Proliferator-Activated Receptors In
    199 REVIEW Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition P Froment, F Gizard1, D Defever2, B Staels1, J Dupont3 and P Monget3 INSERM U.418, UMR Communications Cellulaire et Différenciation, Hôpital Debrousse, 29 rue Soeur Bouvier, 69322 Lyon, France 1INSERM U.545, Institut Pasteur de Lille et Faculté de Pharmacie Université de Lille 2, 1 rue du Pr Calmette, 59019 Lille, France 2LMCB, Department of Molecular Biomedical Research, V.I.B., Technologiepark 927, B-9052 Ghent (Zwijnaarde), Belgium 3Physiologie de la reproduction et des comportements, UMR 6175 INRA-CNRS-Université F. Rabelais de Tours-Haras Nationaux, 37380 Nouzilly, France (Requests for offprints should be addressed to P Froment; [email protected]) Abstract Peroxisome proliferator-activated receptors (PPAR, granulosa cell proliferation and steroidogenesis in vitro. All PPAR/ and PPAR) are a family of nuclear receptors these recent data raise new questions about the biologic that are activated by binding of natural ligands, such as actions of PPARs in reproduction and their use in polyunsaturated fatty acids or by synthetic ligands. Syn- therapeutic treatments of fertility troubles such as PCOS thetic molecules of the glitazone family, which bind to or endometriosis. In this review, we first describe the roles PPAR, are currently used to treat type II diabetes and of PPARs in different compartments of the reproductive also to attenuate the secondary clinical symptoms fre- axis (from male and female gametogenesis to parturition), quently associated with insulin resistance, including poly- with a focus on PPAR. Secondly, we discuss the possible cystic ovary syndrome (PCOS). PPARs are expressed molecular mechanisms underlying the effect of glitazones in different compartments of the reproductive system on PCOS.
    [Show full text]
  • Antiviral Activities of Oleanolic Acid and Its Analogues
    molecules Review Antiviral Activities of Oleanolic Acid and Its Analogues Vuyolwethu Khwaza, Opeoluwa O. Oyedeji and Blessing A. Aderibigbe * Department of Chemistry, University of Fort Hare, Alice Campus, Alice 5700, Eastern Cape, South Africa; [email protected] (V.K.); [email protected] (O.O.O) * Correspondence: [email protected]; Tel.: +27-406022266; Fax: +08-67301846 Academic Editors: Patrizia Ciminiello, Alfonso Mangoni, Marialuisa Menna and Orazio Taglialatela-Scafati Received: 27 July 2018; Accepted: 5 September 2018; Published: 9 September 2018 Abstract: Viral diseases, such as human immune deficiency virus (HIV), influenza, hepatitis, and herpes, are the leading causes of human death in the world. The shortage of effective vaccines or therapeutics for the prevention and treatment of the numerous viral infections, and the great increase in the number of new drug-resistant viruses, indicate that there is a great need for the development of novel and potent antiviral drugs. Natural products are one of the most valuable sources for drug discovery. Most natural triterpenoids, such as oleanolic acid (OA), possess notable antiviral activity. Therefore, it is important to validate how plant isolates, such as OA and its analogues, can improve and produce potent drugs for the treatment of viral disease. This article reports a review of the analogues of oleanolic acid and their selected pathogenic antiviral activities, which include HIV, the influenza virus, hepatitis B and C viruses, and herpes viruses. Keywords: HIV; influenza virus; HBV/HCV; natural product; triterpenoids; medicinal plant 1. Introduction Viral diseases remain a major problem for humankind. It has been reported in some reviews that there is an increase in the number of viral diseases responsible for death and morbidity around the world [1,2].
    [Show full text]
  • PDE4-Inhibitors: a Novel, Targeted Therapy for Obstructive Airways Disease Zuzana Diamant, Domenico Spina
    PDE4-inhibitors: A novel, targeted therapy for obstructive airways disease Zuzana Diamant, Domenico Spina To cite this version: Zuzana Diamant, Domenico Spina. PDE4-inhibitors: A novel, targeted therapy for obstructive airways disease. Pulmonary Pharmacology & Therapeutics, 2011, 24 (4), pp.353. 10.1016/j.pupt.2010.12.011. hal-00753954 HAL Id: hal-00753954 https://hal.archives-ouvertes.fr/hal-00753954 Submitted on 20 Nov 2012 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Accepted Manuscript Title: PDE4-inhibitors: A novel, targeted therapy for obstructive airways disease Authors: Zuzana Diamant, Domenico Spina PII: S1094-5539(11)00006-X DOI: 10.1016/j.pupt.2010.12.011 Reference: YPUPT 1071 To appear in: Pulmonary Pharmacology & Therapeutics Received Date: 2 October 2010 Revised Date: 5 December 2010 Accepted Date: 24 December 2010 Please cite this article as: Diamant Z, Spina D. PDE4-inhibitors: A novel, targeted therapy for obstructive airways disease, Pulmonary Pharmacology & Therapeutics (2011), doi: 10.1016/j.pupt.2010.12.011 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript.
    [Show full text]
  • The Single Cyclic Nucleotide-Specific Phosphodiesterase of the Intestinal Parasite Giardia Lamblia Represents a Potential Drug Target
    RESEARCH ARTICLE The single cyclic nucleotide-specific phosphodiesterase of the intestinal parasite Giardia lamblia represents a potential drug target Stefan Kunz1,2*, Vreni Balmer1, Geert Jan Sterk2, Michael P. Pollastri3, Rob Leurs2, Norbert MuÈ ller1, Andrew Hemphill1, Cornelia Spycher1¤ a1111111111 1 Institute of Parasitology, Vetsuisse Faculty, University of Bern, Bern, Switzerland, 2 Division of Medicinal Chemistry, Faculty of Sciences, Amsterdam Institute of Molecules, Medicines and Systems (AIMMS), Vrije a1111111111 Universiteit Amsterdam, Amsterdam, The Netherlands, 3 Department of Chemistry and Chemical Biology, a1111111111 Northeastern University, Boston, Massachusetts, United States of America a1111111111 a1111111111 ¤ Current address: Euresearch, Head Office Bern, Bern, Switzerland * [email protected] Abstract OPEN ACCESS Citation: Kunz S, Balmer V, Sterk GJ, Pollastri MP, Leurs R, MuÈller N, et al. (2017) The single cyclic Background nucleotide-specific phosphodiesterase of the Giardiasis is an intestinal infection correlated with poverty and poor drinking water quality, intestinal parasite Giardia lamblia represents a potential drug target. PLoS Negl Trop Dis 11(9): and treatment options are limited. According to the Center for Disease Control and Preven- e0005891. https://doi.org/10.1371/journal. tion, Giardia infections afflict nearly 33% of people in developing countries, and 2% of the pntd.0005891 adult population in the developed world. This study describes the single cyclic nucleotide- Editor: Aaron R. Jex, University of Melbourne, specific phosphodiesterase (PDE) of G. lamblia and assesses PDE inhibitors as a new gen- AUSTRALIA eration of anti-giardial drugs. Received: December 5, 2016 Accepted: August 21, 2017 Methods Published: September 15, 2017 An extensive search of the Giardia genome database identified a single gene coding for a class I PDE, GlPDE.
    [Show full text]
  • Penitrem and Thomitrem Formation by Penicillium Crustosum
    Mycopathologia 157: 349–357, 2004. 349 © 2004 Kluwer Academic Publishers. Printed in the Netherlands. Penitrem and thomitrem formation by Penicillium crustosum Thomas Rundberget1, Ida Skaar1, Oloff O’Brien2 & Arne Flåøyen1 1National Veterinary Institute, PO Box 8156 Dep., 0033 Oslo, Norway; 2ARC Plant Protection, Research Institute, Private Bag X134, Pretoria 0001, South Africa Received 9 September 2002; accepted in final form 16 July 2003 Abstract The levels of penitrems A, B, C, D, E, F, roquefortine C and thomitrem A and E recovered from extracts of 36 Norwegian, 2 American and one each of Japanese, German, South African, Danish and Fijian isolates of Penicillum crustosum Thom were quantitatively determined using high performance liquid chromatography-mass spectrometry (HPLC-MS). Forty-two of the 44 isolates of penitrem-producing isolates grown on rice, afforded levels of thomitrem A and E comparable to that of penitrem A. Thomitrems A and E were also found, but at lower levels, when cultures were grown on barley. No thomitrems were found when the isolates were grown on liquid media. The effects of time and temperature on mycotoxin formation were studied on rice over a 4 week period at 10, 15 and 25 ◦C, respectively. No mycotoxins could be detected after 1 week at 10 ◦C, but after 2 weeks at 10 ◦C levels were similar to those produced at 15 and 25 ◦C. Higher levels of thomitrems A and E were detected when media were maintained at lower pH. The possibility that thomitrems A and E might be derived by acid promoted conversion of penitrems A and E was explored in stability trials performed at pH 2, 3, 4, 5 and 7 in the presence and absence of media.
    [Show full text]
  • Central Valley Toxicology Drug List
    Chloroform ~F~ Lithium ~A~ Chlorpheniramine Loratadine Famotidine Acebutolol Chlorpromazine Lorazepam Fenoprofen Acetaminophen Cimetidine Loxapine Fentanyl Acetone Citalopram LSD (Lysergide) Fexofenadine 6-mono- Clomipramine acetylmorphine Flecainide ~M~ Clonazepam a-Hydroxyalprazolam Fluconazole Maprotiline Clonidine a-Hydroxytriazolam Flunitrazepam MDA Clorazepate Albuterol Fluoxetine MDMA Clozapine Alprazolam Fluphenazine Medazepam Cocaethylene Amantadine Flurazepam Meperidine Cocaine 7-Aminoflunitrazepam Fluvoxamine Mephobarbital Codeine Amiodarone Fosinopril Meprobamate Conine Amitriptyline Furosemide Mesoridazine Cotinine Amlodipine Methadone Cyanide ~G~ Amobarbital Methanol Cyclobenzaprine Gabapentin Amoxapine d-Methamphetamine Cyclosporine GHB d-Amphetamine l-Methamphetamine Glutethamide l-Amphetamine ~D~ Methapyrilene Guaifenesin Aprobarbital Demoxepam Methaqualone Atenolol Desalkylfurazepam ~H~ Methocarbamol Atropine Desipramine Halazepam Methylphenidate ~B~ Desmethyldoxepin Haloperidol Methyprylon Dextromethoraphan Heroin Metoclopramide Baclofen Diazepam Hexobarbital Metoprolol Barbital Digoxin Hydrocodone Mexiletine Benzoylecgonine Dihydrocodein Hydromorphone Midazolam Benzphetamine Dihydrokevain Hydroxychloroquine Mirtazapine Benztropine Diltiazem Hydroxyzine Morphine (Total/Free) Brodificoum Dimenhydrinate Bromazepam ~N~ Diphenhydramine ~I~ Bupivacaine Nafcillin Disopyramide Ibuprofen Buprenorphine Naloxone Doxapram Imipramine Bupropion Naltrexone Doxazosin Indomethacin Buspirone NAPA Doxepin Isoniazid Butabarbital Naproxen
    [Show full text]
  • Possible Fungistatic Implications of Betulin Presence in Betulaceae Plants and Their Hymenochaetaceae Parasitic Fungi Izabela Jasicka-Misiak*, Jacek Lipok, Izabela A
    Possible Fungistatic Implications of Betulin Presence in Betulaceae Plants and their Hymenochaetaceae Parasitic Fungi Izabela Jasicka-Misiak*, Jacek Lipok, Izabela A. S´wider, and Paweł Kafarski Faculty of Chemistry, Opole University, Oleska 48, 45-052 Opole, Poland. Fax: +4 87 74 52 71 15. E-mail: [email protected] * Author for correspondence and reprint requests Z. Naturforsch. 65 c, 201 – 206 (2010); received September 23/October 26, 2009 Betulin and its derivatives (especially betulinic acid) are known to possess very interesting prospects for their application in medicine, cosmetics and as bioactive agents in pharmaceu- tical industry. Usually betulin is obtained by extraction from the outer layer of a birch bark. In this work we describe a simple method of betulin isolation from bark of various species of Betulaceae trees and parasitic Hymenochaetaceae fungi associated with these trees. The composition of the extracts was studied by GC-MS, whereas the structures of the isolated compounds were confi rmed by FTIR and 1H NMR. Additionally, the signifi cant fungistatic activity of betulin towards some fi lamentous fungi was determined. This activity was found to be strongly dependent on the formulation of this triterpene. A betulin-trimyristin emul- sion, in which nutmeg fat acts as emulsifi er and lipophilic carrier, inhibited the fungal growth even in micromolar concentrations – its EC50 values were established in the range of 15 up to 50 μM depending on the sensitivity of the fungal strain. Considering the lack of fungistatic effect of betulin applied alone, the application of ultrasonic emulsifi cation with the natural plant fat trimyristin appeared to be a new method of antifungal bioassay of water-insoluble substances, such as betulin.
    [Show full text]
  • (BK) Channel Antagonist Penitrem a As a Novel Breast Cancer-Targeted Therapeutic
    marine drugs Article The Maxi-K (BK) Channel Antagonist Penitrem A as a Novel Breast Cancer-Targeted Therapeutic Amira A. Goda 1, Abu Bakar Siddique 1 ID , Mohamed Mohyeldin 1,3, Nehad M. Ayoub 2 ID and Khalid A. El Sayed 1,* ID 1 Department of Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USA; [email protected] (A.A.G.); [email protected] (A.B.S.); [email protected] (M.M.) 2 Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan; [email protected] 3 Department of Pharmacognosy, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt * Correspondence: [email protected]; Tel.: +1-318-342-1725 Received: 6 April 2018; Accepted: 9 May 2018; Published: 11 May 2018 Abstract: Breast cancer (BC) is a heterogeneous disease with different molecular subtypes. The high conductance calcium-activated potassium channels (BK, Maxi-K channels) play an important role in the survival of some BC phenotypes, via membrane hyperpolarization and regulation of cell cycle. BK channels have been implicated in BC cell proliferation and invasion. Penitrems are indole diterpene alkaloids produced by various terrestrial and marine Penicillium species. Penitrem A (1) is a selective BK channel antagonist with reported antiproliferative and anti-invasive activities against multiple malignancies, including BC. This study reports the high expression of BK channel in different BC subtypes. In silico BK channel binding affinity correlates with the antiproliferative activities of selected penitrem analogs. 1 showed the best binding fitting at multiple BK channel crystal structures, targeting the calcium-sensing aspartic acid moieties at the calcium bowel and calcium binding sites.
    [Show full text]